Still benched on its way to the bedside: Sphingosine kinase 1 as an emerging target in cancer chemotherapy

Critical Reviews in Biochemistry and Molecular Biology

Volumn 46, Issue 4, 2011, Pages 342-351

  Gault, Christopher R ^a   Obeid, Lina M ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Ceramide; Chemoresistance; Oncogene; Sphingolipids; Sphingosine 1 phosphate

Indexed keywords

CERAMIDE; CISPLATIN; FINGOLIMOD; PHOSPHOTRANSFERASE INHIBITOR; SAFINGOL; SPHINGOLIPID; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 1;

ANCHORAGE INDEPENDENT GROWTH; ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL FATE; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; ENZYME INHIBITION; ENZYME MECHANISM; GENE OVEREXPRESSION; LYMPHANGIOGENESIS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR;

ANIMALS; CELL PROLIFERATION; CERAMIDES; CLINICAL TRIALS AS TOPIC; HUMANS; LYSOPHOSPHOLIPIDS; MICE; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SIGNAL TRANSDUCTION; SPHINGOLIPIDS; SPHINGOSINE;

MUS;

EID: 79960778361     PISSN: 10409238     EISSN: 15497798     Source Type: Journal    
DOI: 10.3109/10409238.2011.597737     Document Type: Review

References (80)

1. Ahn EH, Schroeder JJ. 2002. Sphingoid bases and ceramide induce apoptosis in HT-29 and HCT-116 human colon cancer cells. Exp Biol Med (Maywood) 227:345-353.
2. Allende ML, Yamashita T, Proia RL. 2003. G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. Blood 102:3665-3667. (Pubitemid 37409386)
3. Anelli V, Gault CR, Cheng AB, Obeid LM. 2008. Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells. Role of hypoxia-inducible factors 1 and 2. J Biol Chem 283:3365-3375.
4. Anelli V, Gault CR, Snider AJ, Obeid LM. 2010. Role of sphingosine kinase-1 in paracrine/transcellular angiogenesis and lymphangiogenesis in vitro. FASEB J 24:2727-2738.
5. Beljanski V, Knaak C, Zhuang Y, Smith CD. 2010. Combined anticancer efects of sphingosine kinase inhibitors and sorafenib. Invest New Drugs 〈Volume〉:.
6. Bonhoure E, Pchejetski D, Aouali N, Morjani H, Levade T, Kohama T, Cuvillier O. 2006. Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1. Leukemia 20:95-102.
7. Caballero S, Swaney J, Moreno K, Afzal A, Kielczewski J, Stoller G, Cavalli A, Garland W, Hansen G, Sabbadini R, Grant MB. 2009. Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fbrosis in a murine model of laser-induced choroidal neovascularization. Exp Eye Res 88:367-377.
8. Carlson CM, Endrizzi BT, Wu J, Ding X, Weinreich MA, Walsh ER, Wani MA, Lingrel JB, Hogquist KA, Jameson SC. 2006. Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature 442:299-302. (Pubitemid 44114904)
9. Chae SS, Paik JH, Furneaux H, Hla T. 2004. Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference. J Clin Invest 114:1082-1089. (Pubitemid 39578697)
10. Cuvillier O. 2007. Sphingosine kinase-1-a potential therapeutic target in cancer. Anticancer Drugs 18:105-110. (Pubitemid 44967421)
11. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind S, Spiegel S. 1996. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381:800-803. (Pubitemid 26243122)
12. Dickson MA, Carvajal RD, Merrill AH Jr, Gonen M, Cane LM, Schwartz GK. 2011. A phase I clinical trial of safngol in combination with cisplatin in advanced solid tumors. Clin Cancer Res 17:2484-2492.
13. Edsall LC, Van Brocklyn JR, Cuvillier O, Kleuser B, Spiegel S. 1998. N,N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide. Biochemistry 37:12892-12898. (Pubitemid 28433522)
14. French KJ, Schrecengost RS, Lee BD, Zhuang Y, Smith SN, Eberly JL, Yun JK, Smith CD. 2003. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 63:5962-5969. (Pubitemid 37187498)
15. Fuereder T, Hoefmayer D, Jaeger-Lansky A, Rasin-Streden D, Strommer S, Fisker N, Hansen BJ, Crevenna R, Wacheck V. 2011. Sphingosine kinase 1 is a relevant molecular target in gastric cancer. Anticancer Drugs 22:245-252.
16. Gonelli A, Mischiati C, Guerrini R, Voltan R, Salvadori S, Zauli G. 2009. Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents. Mini Rev Med Chem 9:498-509.
17. Hait NC, Allegood J, Maceyka M, Strub GM, Harikumar KB, Singh SK, Luo C, Marmorstein R, Kordula T, Milstien S, Spiegel S. 2009. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325:1254-1257.
18. Hannun YA, Luberto C, Argraves KM. 2001. Enzymes of sphingolipid metabolism: from modular to integrative signaling. Biochemistry 40:4893-4903. (Pubitemid 32332534)
19. Hannun YA, Obeid LM. 2008. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9:139-150. (Pubitemid 351158911)
20. Johnson KR, Johnson KY, Crellin HG, Ogretmen B, Boylan AM, Harley RA, Obeid LM. 2005. Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue. J Histochem Cytochem 53:1159-1166. (Pubitemid 41262984)
21. Kaur B, Khwaja FW, Severson EA, Matheny SL, Brat DJ, Van Meir EG. 2005. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro-oncology 7:134-153. (Pubitemid 40590514)
22. Kawamori T, Kaneshiro T, Okumura M, Maalouf S, Ufacker A, Bielawski J, Hannun YA, Obeid LM. 2009. Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J 23:405-414.
23. Kedderis LB, Bozigian HP, Kleeman JM, Hall RL, Palmer TE, Harrison SD Jr, Susick RL Jr. 1995. Toxicity of the protein kinase C inhibitor safngol administered alone and in combination with chemotherapeutic agents. Fundam Appl Toxicol 25:201-217.
24. Knapp P, Baranowski M, Knapp M, Zabielski P, Blachnio-Zabielska AU, Górski J. 2010. Altered sphingolipid metabolism in human endometrial cancer. Prostaglandins Other Lipid Mediat 92:62-66.
25. Kohno M, Momoi M, Oo ML, Paik JH, Lee YM, Venkataraman K, Ai Y, Ristimaki AP, Fyrst H, Sano H, Rosenberg D, Saba JD, Proia RL, Hla T. 2006. Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation. Mol Cell Biol 26:7211-7223. (Pubitemid 44477697)
26. Kono M, Mi Y, Liu Y, Sasaki T, Allende ML, Wu YP, Yamashita T, Proia RL. 2004. The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis. J Biol Chem 279:29367-29373. (Pubitemid 38915815)
27. Le Stunf H, Giussani P, Maceyka M, Lépine S, Milstien S, Spiegel S. 2007. Recycling of sphingosine is regulated by the concerted actions of sphingosine-1-phosphate phosphohydrolase 1 and sphingosine kinase 2. J Biol Chem 282:34372-34380. (Pubitemid 350159464)
28. Lee MJ, Van Brocklyn JR, Tangada S, Liu CH, Hand AR, Menzeleev R, Spiegel S, Hla T. 1998. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279:1552-1555. (Pubitemid 28217081)
29. Lee OH, Kim YM, Lee YM, Moon EJ, Lee DJ, Kim JH, Kim KW, Kwon YG. 1999. Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem Biophys Res Commun 264:743-750.
30. Levy M, Futerman AH. 2010. Mammalian ceramide synthases. IUBMB Life 62:347-356.
31. Li J, Guan HY, Gong LY, Song LB, Zhang N, Wu J, Yuan J, Zheng YJ, Huang ZS, Li M. 2008. Clinical signifcance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival. Clin Cancer Res 14:6996-7003.
32. Li MH, Sanchez T, Yamase H, Hla T, Oo ML, Pappalardo A, Lynch KR, Lin CY, Ferrer F. 2009a. S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumor. Cancer Lett 276:171-179.
33. Li W, Yu CP, Xia JT, Zhang L, Weng GX, Zheng HQ, Kong QL, Hu LJ, Zeng MS, Zeng YX, Li M, Li J, Song LB. 2009b. Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients. Clin Cancer Res 15:1393-1399.
34. Liu H, Toman RE, Goparaju SK, Maceyka M, Nava VE, Sankala H, Payne SG, Bektas M, Ishii I, Chun J, Milstien S, Spiegel S. 2003. Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis. J Biol Chem 278:40330-40336. (Pubitemid 37248601)
35. Liu Y, Wada R, Yamashita T, Mi Y, Deng CX, Hobson JP, Rosenfeldt HM, Nava VE, Chae SS, Lee MJ, Liu CH, Hla T, Spiegel S, Proia RL. 2000. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 106:951-961.
36. Liu G, Zheng H, Zhang Z, Wu Z, Xiong H, Li J, Song L. 2010. Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy. BMC Cancer 10:495.
37. Maceyka M, Sankala H, Hait NC, Le Stunf H, Liu H, Toman R, Collier C, Zhang M, Satin LS, Merrill AH Jr, Milstien S, Spiegel S. 2005. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J Biol Chem 280:37118-37129. (Pubitemid 41587796)
38. Malavaud B, Pchejetski D, Mazerolles C, de Paiva GR, Calvet C, Doumerc N, Pitson S, Rischmann P, Cuvillier O. 2010. Sphingosine kinase-1 activity and expression in human prostate cancer resection specimens. Eur J Cancer 46:3417-3424.
39. Min J, Stegner AL, Alexander H, Alexander S. 2004. Overexpression of sphingosine-1-phosphate lyase or inhibition of sphingosine kinase in Dictyostelium discoideum results in a selective increase in sensitivity to platinum-based chemotherapy drugs. Eukaryotic Cell 3:795-805. (Pubitemid 38763866)
40. Min J, Traynor D, Stegner AL, Zhang L, Hanigan MH, Alexander H, Alexander S. 2005. Sphingosine kinase regulates the sensitivity of Dictyostelium discoideum cells to the anticancer drug cisplatin. Eukaryotic Cell 4:178-189. (Pubitemid 40234435)
41. Mizugishi K, Yamashita T, Olivera A, Miller GF, Spiegel S, Proia RL. 2005. Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol 25:11113-11121. (Pubitemid 41747151)
42. Mukhopadhyay A, Saddoughi SA, Song P, Sultan I, Ponnusamy S, Senkal CE, Snook CF, Arnold HK, Sears RC, Hannun YA, Ogretmen B. 2009. Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling. FASEB J 23:751-763.
43. Nava VE, Hobson JP, Murthy S, Milstien S, Spiegel S. 2002. Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. Exp Cell Res 281:115-127. (Pubitemid 35373788)
44. Oliver L, Olivier C, Marhuenda FB, Campone M, Vallette FM. 2009. Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy. Curr Mol Pharmacol 2:263-284.
45. Olivera A, Spiegel S. 1993. Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 365:557-560. (Pubitemid 23317779)
46. Oskouian B, Sooriyakumaran P, Borowsky AD, Crans A, Dillard-Telm L, Tam YY, Bandhuvula P, Saba JD. 2006. Sphingosine-1-phosphate lyase potentiates apoptosis via p53-and p38-dependent pathways and is down-regulated in colon cancer. Proc Natl Acad Sci USA 103:17384-17389. (Pubitemid 44788978)
47. Paugh SW, Paugh BS, Rahmani M, Kapitonov D, Almenara JA, Kordula T, Milstien S, Adams JK, Zipkin RE, Grant S, Spiegel S. 2008. A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia. Blood 112:1382-1391.
48. Pchejetski D, Doumerc N, Golzio M, Naymark M, Teissié J, Kohama T, Waxman J, Malavaud B, Cuvillier O. 2008. Chemosensitizing efects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models. Mol Cancer Ter 7:1836-1845.
49. Pchejetski D, Golzio M, Bonhoure E, Calvet C, Doumerc N, Garcia V, Mazerolles C, Rischmann P, Teissié J, Malavaud B, Cuvillier O. 2005. Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. Cancer Res 65:11667-11675. (Pubitemid 41821727)
50. Pitson SM, Xia P, Leclercq TM, Moretti PA, Zebol JR, Lynn HE, Wattenberg BW, Vadas MA. 2005. Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling. J Exp Med 201:49-54. (Pubitemid 40130083)
51. Ruckhäberle E, Rody A, Engels K, Gaetje R, von Minckwitz G, Schifmann S, Grösch S, Geisslinger G, Holtrich U, Karn T, Kaufmann M. 2008. Microarray analysis of altered sphingolipid metabolism reveals prognostic signifcance of sphingosine kinase 1 in breast cancer. Breast Cancer Res Treat 112:41-52.
52. Sakakura C, Sweeney EA, Shirahama T, Hagiwara A, Yamaguchi T, Takahashi T, Hakomori S, Igarashi Y. 1998. Selectivity of sphingosine-induced apoptosis. Lack of activity of DL-erythyro-dihydrosphingosine. Biochem Biophys Res Commun 246: 827-830. (Pubitemid 28420943)
53. Sauer L, Nunes J, Salunkhe V, Skalska L, Kohama T, Cuvillier O, Waxman J, Pchejetski D. 2009. Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel. Int J Cancer 125:2728-2736.
54. Schwalm S, Döll F, Römer I, Bubnova S, Pfeilschifter J, Huwiler A. 2008. Sphingosine kinase-1 is a hypoxia-regulated gene that stimulates migration of human endothelial cells. Biochem Biophys Res Commun 368:1020-1025.
55. Selzner M, Bielawska A, Morse MA, Rüdiger HA, Sindram D, Hannun YA, Clavien PA. 2001. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res 61:1233-1240. (Pubitemid 32174448)
56. Senkal CE, Ponnusamy S, Rossi MJ, Bialewski J, Sinha D, Jiang JC, Jazwinski SM, Hannun YA, Ogretmen B. 2007. Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas. Mol Cancer Ter 6:712-722. (Pubitemid 46332472)
57. Shida D, Takabe K, Kapitonov D, Milstien S, Spiegel S. 2008. Targeting SphK1 as a new strategy against cancer. Curr Drug Targets 9:662-673.
58. Shirai K, Kaneshiro T, Wada M, Furuya H, Bielawski J, Hannun YA, Obeid LM, Ogretmen B, Kawamori T. 2011. A role of sphingosine kinase 1 in head and neck carcinogenesis. Cancer Prev Res (Phila) 4:454-462.
59. Sinha UK, Schorn VJ, Hochstim C, Chinn SB, Zhu S, Masood R. 2011. Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition. Head Neck 33:178-188.
60. Snider AJ, Orr Gandy KA, Obeid LM. 2010. Sphingosine kinase: Role in regulation of bioactive sphingolipid mediators in infammation. Biochimie 92:707-715.
61. Sobue S, Iwasaki T, Sugisaki C, Nagata K, Kikuchi R, Murakami M, Takagi A, Kojima T, Banno Y, Akao Y, Nozawa Y, Kannagi R, Suzuki M, Abe A, Naoe T, Murate T. 2006. Quantitative RT-PCR analysis of sphingolipid metabolic enzymes in acute leukemia and myelodysplastic syndromes. Leukemia 20:2042-2046. (Pubitemid 44614898)
62. Sobue S, Murakami M, Banno Y, Ito H, Kimura A, Gao S, Furuhata A, Takagi A, Kojima T, Suzuki M, Nozawa Y, Murate T. 2008. v-Src oncogene product increases sphingosine kinase 1 expression through mRNA stabilization: alteration of AU-rich element-binding proteins. Oncogene 27:6023-6033.
63. Song L, Xiong H, Li J, Liao W, Wang L, Wu J, Li M. 2011. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-B pathway in human non-small cell lung cancer. Clin Cancer Res 17:1839-1849.
64. Spiegel S, Cuvillier O, Edsall LC, Kohama T, Menzeleev R, Olah Z, Olivera A, Pirianov G, Tomas DM, Tu Z, Van Brocklyn JR, Wang F. 1998. Sphingosine-1-phosphate in cell growth and cell death. Ann N Y Acad Sci 845:11-18. (Pubitemid 28365296)
65. Strub GM, Paillard M, Liang J, Gomez L, Allegood JC, Hait NC, Maceyka M, Price MM, Chen Q, Simpson DC, Kordula T, Milstien S, Lesnefsky EJ, Spiegel S. 2011. Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration. FASEB J 25:600-612.
66. Sukocheva O, Wang L, Verrier E, Vadas MA, Xia P. 2009. Restoring endocrine response in breast cancer cells by inhibition of the sphingosine kinase-1 signaling pathway. Endocrinology 150:4484-4492.
67. Sukocheva OA, Wang L, Albanese N, Pitson SM, Vadas MA, Xia P. 2003. Sphingosine kinase transmits estrogen signaling in human breast cancer cells. Mol Endocrinol 17:2002-2012. (Pubitemid 37281793)
68. Taha TA, El-Alwani M, Hannun YA, Obeid LM. 2006. Sphingosine kinase-1 is cleaved by cathepsin B in vitro: identifcation of the initial cleavage sites for the protease. FEBS Lett 580:6047-6054. (Pubitemid 44666785)
69. Taha TA, Kitatani K, Bielawski J, Cho W, Hannun YA, Obeid LM. 2005. Tumor necrosis factor induces the loss of sphingosine kinase-1 by a cathepsin B-dependent mechanism. J Biol Chem 280:17196-17202. (Pubitemid 41389186)
70. Taha TA, Kitatani K, El-Alwani M, Bielawski J, Hannun YA, Obeid LM. 2006. Loss of sphingosine kinase-1 activates the intrinsic pathway of programmed cell death: modulation of sphingolipid levels and the induction of apoptosis. FASEB J 20:482-484. (Pubitemid 46671223)
71. Taha TA, Osta W, Kozhaya L, Bielawski J, Johnson KR, Gillanders WE, Dbaibo GS, Hannun YA, Obeid LM. 2004. Down-regulation of sphingosine kinase-1 by DNA damage: dependence on proteases and p53. J Biol Chem 279:20546-20554. (Pubitemid 38623502)
72. Tengood JE, Kovach KM, Vescovi PE, Russell AJ, Little SR. 2010. Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis. Biomaterials 31:7805-7812.
73. Van Brocklyn JR, Jackson CA, Pearl DK, Kotur MS, Snyder PJ, Prior TW. 2005. Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J Neuropathol Exp Neurol 64:695-705. (Pubitemid 41177111)
74. Venable ME, Webb-Froehlich LM, Sloan EF, Tomley JE. 2006. Shift in sphingolipid metabolism leads to an accumulation of ceramide in senescence. Mech Ageing Dev 127:473-480.
75. Venable ME, Yin X. 2009. Ceramide induces endothelial cell senescence. Cell Biochem Funct 27:547-551.
76. Visentin B, Vekich JA, Sibbald BJ, Cavalli AL, Moreno KM, Matteo RG, Garland WA, Lu Y, Yu S, Hall HS, Kundra V, Mills GB, Sabbadini RA. 2006. Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 9:225-238. (Pubitemid 43357948)
77. White-Gilbertson S, Mullen T, Senkal C, Lu P, Ogretmen B, Obeid L, Voelkel-Johnson C. 2009. Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells. Oncogene 28:1132-1141.
78. Wu J, Bohanan CS, Neumann JC, Lingrel JB. 2008. KLF2 transcription factor modulates blood vessel maturation through smooth muscle cell migration. J Biol Chem 283:3942-3950.
79. Wu J, Spiegel S, Sturgill TW. 1995. Sphingosine 1-phosphate rapidly activates the mitogen-activated protein kinase pathway by a G protein-dependent mechanism. J Biol Chem 270:11484-11488.
80. Xia P, Gamble JR, Wang L, Pitson SM, Moretti PA, Wattenberg BW, D'Andrea RJ, Vadas MA. 2000. An oncogenic role of sphingosine kinase. Curr Biol 10:1527-1530. (Pubitemid 32003646)